Summary slide.png (113.37 kB)
Real World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre
media
posted on 2020-11-26, 09:44 authored by F. C. Kreeshan, A. Al-Janabi, R.B. Warren, H. J. A. HunterArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
